The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S-E Al-BatranArbeitsgemeinschaft Internistische Onkologie (AIO)

Abstract

Docetaxel is a widely used cytotoxic agent. This study evaluates the impact of docetaxel toxicities on patient's health-related quality of life (QoL). We conducted a multicenter, prospective, non-interventional trial, in which the QoL was assessed using the EORTC QLQ-C30 questionnaires at baseline and every 4 weeks up to 40 weeks in patients receiving a docetaxel-based chemotherapy for metastatic disease. Treatment-related adverse events were correlated with the corresponding QoL scores. Uni- and multivariate analyses were applied. From January 2008 to June 2011, a total of 2659 patients were included. The majority of patients (48.1%) had prostate cancer, followed by breast (17.1%) and non-small-cell-lung cancer (15.8%). Patients received a median of 5 docetaxel cycles with the median dose of 75 mg/m(2). The presence of grade 3/4 diarrhea showed the strongest effect on global health status/QoL average scores (50.91 versus 33.06), followed by vomiting (50.91 versus 35.17), dyspnea (50.94 versus 35.81), mucositis/stomatitis (50.88 versus 36.41), nausea (50.91 versus 36.68), infection (50.90 versus 37.14), fatigue (50.90 versus 43.82) and anemia (50.91 versus 41.03), P < 0.05 for all comparisons. Grade 3/4 leukopenia/neutropenia, ...Continue Reading

References

Oct 13, 2004·The Oncologist·John D Hainsworth
Jan 29, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Barry V FortnerBrad S Stolshek
Jul 12, 2005·BMC Nursing·Barry V FortnerLee S Schwartzberg
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemUNKNOWN V325 Study Group
May 29, 2007·Journal of Pain and Symptom Management·Digant GuptaJames F Grutsch
Aug 1, 2007·The Oncologist·Maarten HofmanGary R Morrow
Jul 11, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lynne I WagnerDavid Cella
Jan 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolyn C GotayFabio Efficace
Mar 7, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Petra FeyerMonika Behrens
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeff A SloanPing Yang
Jun 1, 2013·The European Respiratory Journal·Christer JansonPeter Burney

❮ Previous
Next ❯

Citations

Nov 12, 2015·Therapeutic Advances in Gastroenterology·Kate YoungIan Chau
Jun 7, 2017·Physiological Reports·Thomas ChaillouJohanna T Lanner
May 8, 2018·Oncology Research and Treatment·Karin BergerHelmut Ostermann
Jan 29, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mark de MolJoachim G Aerts
Apr 14, 2016·Cancer Nursing·Maria Fernanda Barbirato da Mata TiezziLúcia Alves Silva Lara
Apr 22, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A R T BerginP de Souza
Jun 23, 2019·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Beate RauUNKNOWN Peritoneum Surface Oncology Group and members of the StuDoQ|Peritoneum Registry of the German Society for General and Viscer
Sep 26, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Sharon Odeo, Amsalu Degu
Jan 12, 2021·Bulletin du cancer·Sonia Ben NasrAbderrazek Haddaoui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.